The Ebola epidemic is ongoing in West Africa and responses from China are positive.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4409763)

Published in Mil Med Res on April 03, 2015

Authors

Jing-Min Zhao1, Shi-Jun Dong2, Jin Li3, Jun-Sheng Ji3

Author Affiliations

1: Department of Pathology and Hepatology, Beijing 302 Hospital, Beijing, 100039 China.
2: Center of Medical Information, Beijing 302 Hospital, Beijing, 100039 China.
3: Department of Infectious Diseases, Beijing 302 Hospital, Beijing, 100039 China.

Articles cited by this

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65

The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature (2014) 6.94

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 4.67

A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89

Ebola virus disease in West Africa--clinical manifestations and management. N Engl J Med (2014) 3.73

Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol (2001) 3.41

Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 3.04

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell (2002) 2.80

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol (2003) 2.75

Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med (2011) 2.47

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol (2005) 2.27

What clinicians should know about the 2014 Ebola outbreak. Mayo Clin Proc (2014) 2.14

Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis (2007) 1.63

Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J Virol (2003) 1.60

Prevention of lymphocyte apoptosis--a potential treatment of sepsis? Clin Infect Dis (2005) 1.58

Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften (1999) 1.05

Risk of imported Ebola virus disease in China. Travel Med Infect Dis (2014) 1.01

Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg Infect Dis (2007) 0.93

Ebola virus outbreak 2014: clinical review for emergency physicians. Ann Emerg Med (2014) 0.87

World struggles to stop Ebola. Nature (2014) 0.79

[The properties of Ebola virus proteins]. Vopr Virusol (2007) 0.78